Home » Topics » Hematologic, BioWorld Science

Hematologic, BioWorld Science
RSS

New antiplatelet agents described by Thomae

Dec. 17, 1996

FDA panel recommends approval of BeneFix

Dec. 13, 1996

DuPont Merck reports pharmacokinetic data for novel gpIIb/IIIa antagonist

Dec. 13, 1996

Novel mechanism of action reported for Xenova PAI inhibitor

Dec. 13, 1996

Warfarin underused for stroke prevention

Dec. 11, 1996

Antithrombin III advances to phase II

Dec. 11, 1996

Allelix reports thrombospondin-derived antihemorrhagic peptide

Dec. 11, 1996

New thrombin inhibitors under study at Merck & Co.

Dec. 9, 1996

Vascular Therapeutics licenses Recordati compound

Dec. 4, 1996

Merck reveals new thrombin inhibitor series

Dec. 3, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 6, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...